Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Development of sarcoidosis after successful treatment of Cushing's disease].

Problemy endokrinologii·2024
Same author

[Panhypopituitarism as the first manifestation of sarcoidosis: case report].

Problemy endokrinologii·2022
Same author

Reactivity of skin microcirculation as a biomarker of cardiovascular events. Pilot study.

Clinical hemorheology and microcirculation·2021
Same author

[Cases of atypical pulmonary diseases under influence of industrial aerosols].

Meditsina truda i promyshlennaia ekologiia·2015
Same author

[Change in the blood cytokine spectrum in patients with pulmonary sarcoidosis].

Terapevticheskii arkhiv·2013
Same author

[Investigation of lymphocytes activation using a method of coherent phase microscopy].

Vestnik Rossiiskoi akademii meditsinskikh nauk·2012

Related Experiment Videos

[Sarcoidosis: problems in classification].

S A Terpigorev, B A Él' Zeĭn, V M Vereshchagina

    Vestnik Rossiiskoi Akademii Meditsinskikh Nauk
    |August 4, 2012
    PubMed
    Summary

    This article addresses challenges in evaluating sarcoidosis activity, severity, and radiographic signs. A new classification is proposed to better define sarcoidosis forms.

    Area of Science:

    • Pulmonary Medicine
    • Immunology
    • Radiology

    Context:

    • Sarcoidosis diagnosis and management present challenges.
    • Current classifications may not fully capture disease heterogeneity.

    Purpose:

    • To discuss issues in assessing sarcoidosis activity and severity.
    • To review radiographic manifestations and disease course.
    • To propose a revised classification for sarcoidosis.

    Summary:

    • The article examines difficulties in evaluating sarcoidosis, including its activity, severity, and radiographic features.
    • It highlights problems with existing definitions of different sarcoidosis forms.
    • A new classification is suggested to improve disease characterization.

    Related Experiment Videos

    Impact:

    • A refined classification could enhance diagnostic accuracy for sarcoidosis.
    • Improved assessment may lead to more personalized treatment strategies.
    • This work aims to standardize sarcoidosis evaluation and reporting.